​

FibroGen (FGEN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

FGEN Stock Forecast

FibroGen (FGEN) stock forecast, based on 15 Wall Street analysts, predicts a 12-month average price target of $28.00, with a high of $28.00 and a low of $28.00. This represents a 125.26% increase from the last price of $12.43.

- $6 $12 $18 $24 $30 High: $28 Avg: $28 Low: $28 Last Closed Price: $12.43

FGEN Stock Rating

FibroGen stock's rating consensus is Hold, based on 15 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (33.33%), 8 Hold (53.33%), 2 Sell (13.33%), and 0 Strong Sell (0.00%).

Hold
Total 15 0 2 8 5 Strong Sell Sell Hold Buy Strong Buy

FGEN Price Target Upside V Benchmarks

TypeNameUpside
StockFibroGen125.26%
SectorHealthcare Stocks 13.55%
IndustryBiotech Stocks 49.00%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$12.43$12.43$12.43
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 251-1--2
Aug, 251-1--2
Jul, 251-1--2
Jun, 251-1--2
May, 251-1--2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 02, 2023Annabel SamimyStifel Nicolaus$28.00$17.3261.66%125.26%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 07, 2025H.C. WainwrightBuyBuyhold
Jul 31, 2024William BlairMarket PerformMarket Performhold
Jan 30, 2023William BlairOutperformupgrade
Jan 05, 2023Bank of America SecuritiesBuyupgrade

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.11$-3.15$-3.15$-2.92$-1.53----
Avg Forecast$-1.70$-2.50$-3.37$-2.63$-0.80$-0.46$-0.38$0.25$-0.44
High Forecast$-1.67$-2.46$-3.00$-2.56$-0.74$-0.38$-0.32$0.30$-0.37
Low Forecast$-1.72$-2.54$-3.75$-2.69$-0.86$-0.52$-0.44$0.21$-0.51
Surprise %24.12%26.00%-6.53%11.03%91.25%----

Revenue Forecast

$0 $70M $140M $210M $280M $350M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$176.32M$235.31M$140.73M$147.75M$29.62M----
Avg Forecast$212.12M$267.58M$130.85M$164.01M$177.84M$166.17M$178.16M$224.84M$270.40M
High Forecast$214.65M$270.78M$141.92M$184.89M$178.69M$187.32M$178.24M$230.77M$304.82M
Low Forecast$209.58M$264.39M$119.78M$143.13M$176.99M$145.02M$178.08M$218.91M$235.98M
Surprise %-16.88%-12.06%7.55%-9.91%-83.34%----

Net Income Forecast

$-550M $-430M $-310M $-190M $-70M $50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-189.29M$-291.03M$-295.23M$-284.23M$-153.10M----
Avg Forecast$-164.94M$-121.49M$-71.28M$-284.23M$-77.84M$-43.81M$-36.93M$24.64M$-42.81M
High Forecast$-162.39M$-25.48M$10.02M$-39.22M$-72.00M$-36.58M$-30.82M$28.71M$-35.73M
Low Forecast$-167.51M$-217.49M$-152.59M$-529.25M$-83.68M$-51.03M$-43.04M$20.56M$-49.90M
Surprise %14.76%139.56%314.16%-96.69%----

FGEN Forecast FAQ

Is FibroGen stock a buy?

FibroGen stock has a consensus rating of Hold, based on 15 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 8 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that FibroGen is a neutral investment for most analysts.

What is FibroGen's price target?

FibroGen's price target, set by 15 Wall Street analysts, averages $28 over the next 12 months. The price target range spans from $28 at the low end to $28 at the high end, suggesting a potential 125.26% change from the previous closing price of $12.43.

How does FibroGen stock forecast compare to its benchmarks?

FibroGen's stock forecast shows a 125.26% upside, outperforming the average forecast for the healthcare stocks sector (13.55%) and outperforming the biotech stocks industry (49.00%).

What is the breakdown of analyst ratings for FibroGen over the past three months?

  • September 2025: 50.00% Strong Buy, 0% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 50.00% Strong Buy, 0% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • July 2025: 50.00% Strong Buy, 0% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is FibroGen’s EPS forecast?

FibroGen's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.46, marking a -69.93% decrease from the reported $-1.53 in 2024. Estimates for the following years are $-0.38 in 2026, $0.25 in 2027, and $-0.44 in 2028.

What is FibroGen’s revenue forecast?

FibroGen's average annual revenue forecast for its fiscal year ending in December 2025 is $166.17M, reflecting a 460.99% increase from the reported $29.62M in 2024. The forecast for 2026 is $178.16M, followed by $224.84M for 2027, and $270.4M for 2028.

What is FibroGen’s net income forecast?

FibroGen's net income forecast for the fiscal year ending in December 2025 stands at $-43.806M, representing a -71.39% decrease from the reported $-153M in 2024. Projections indicate $-36.931M in 2026, $24.64M in 2027, and $-42.813M in 2028.